Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Human Pathology|August 30, 2006
Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinomaTsui-Lien Mao, Chih-Yi Hsu, May J Yen, et al.
Breast Cancer (Dove Medical Press)|March 18, 2025
Genetic Alterations in HER2-Positive and Equivocal Breast Cancer by ImmunohistochemistryYi-Fang Tsai, Chih-Yi Hsu, Yun-Ning Chiu, et al.
The American Journal of Surgical Pathology|January 4, 2013
Exclusion of histiocytes/endothelial cells and using endothelial cells as internal reference are crucial for interpretation of MGMT immunohistochemistry in glioblastomaChih-Yi Hsu, Shih-Chieh Lin, Hsiang-Ling Ho, et al.
BMC Cancer|February 26, 2021
Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analysesChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Journal of Neuro-Oncology|January 11, 2015
Prognosis of glioblastoma with faint MGMT methylation-specific PCR productChih-Yi Hsu, Hsiang-Ling Ho, Shih-Chieh Lin, et al.
Kidney Research and Clinical Practice|June 27, 2024
Unveiling the enigma of acute kidney disease: predicting prognosis, exploring interventions, and embracing a multidisciplinary approachSzu-Yu Pan, Thomas Tao-Min Huang, Zheng-Hong Jiang, et al.
World Journal of Oncology|January 24, 2025
Correlation Between PIK3R1 Expression and Cell Growth in Human Breast Cancer Cell Line BT-474 and Clinical OutcomesYi-Fang Tsai, Jiun-I Lai, Chun-Yu Liu, et al.
International Journal of Molecular Sciences|January 27, 2024
Genomic Alterations of Tumors in HER2-Low Breast CancersYi-Fang Tsai, Chi-Cheng Huang, Chih-Yi Hsu, et al.
Histopathology|December 6, 2018
HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancerYi-Fang Tsai, Ling-Ming Tseng, Pei-Ju Lien, et al.
Cancer Research and Treatment|December 11, 2025
ITGB2 Gene Gain as a Prognostic Marker for Early Recurrence in Luminal HER2-Negative High Proliferative Breast CancerChun-Yu Liu, Ji-Lin Chen, Yi-Fang Tsai, et al.
Pageof 12